Matches in SemOpenAlex for { <https://semopenalex.org/work/W2923929522> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2923929522 endingPage "196" @default.
- W2923929522 startingPage "195" @default.
- W2923929522 abstract "Obstructive Sleep Apnea syndrome (OSAS), characterized by intermittent hypoxia (IH) cycles during sleep, induces endothelial dysfunction and atherogenesis lesions, which could be mediated by an increase in endothelial permeability. VE-Cadherin (VECad) cleavage, detected by the soluble extracellular fragment released (sVE), may be a key step in this regulation of endothelial permeability. Our aim was to search for sVE in sera from healthy volunteers submitted to IH, and from OSAS patients before and after treatment by continuous positive airway pressure (CPAP) and to characterize mechanisms regulating VECad cleavage in endothelial cells submitted to IH. sVE was searched in sera from 7 healthy volunteers exposed to IH, 44 OSAS patients and 31 control subjects. Human Aortic Endothelial Cells (HAEC) were exposed to 6 hours of IH in vitro, then endothelial permeability was assessed by measuring trans-endothelial electrical resistance (TEER) and VECad cleavage was evaluated by detecting sVE in cells supernatants after treatment by IH and tyrosine kinase inhibitor (30 μM Genistein or 10 μM PP2), HIF-1 inhibitor (1 μM 2-Methoxyestradiol), an anti-oxidant (100 μM Tempol) or anti-hVEGF blocking antibody (0.5 μg/mL). sVE was significantly elevated in healthy volunteers submitted to IH and in OSAS patient sera before treatment, but decreased in OSAS patients after 6 months of CPAP therapy. We found a significant positive correlation between sVE and OSAS severity and between sVE and serum VEGF. In HAEC supernatants, TEER decreased by 37.5% and sVE increased by 39% after cell exposure to IH. These effects were reversed by all the pharmacological inhibitors tested. we suggest that, in OSAS, IH increases endothelial permeability by inducing VECad cleavage via the ROS, HIF1, VEGF and tyrosine kinase pathways. Future studies will determine whether sVE could be a potential biomarker to evaluate early endothelial alterations in OSAS." @default.
- W2923929522 created "2019-04-01" @default.
- W2923929522 creator A5000401587 @default.
- W2923929522 creator A5027498618 @default.
- W2923929522 creator A5030907986 @default.
- W2923929522 creator A5040246127 @default.
- W2923929522 creator A5048658342 @default.
- W2923929522 creator A5061416491 @default.
- W2923929522 creator A5071764115 @default.
- W2923929522 date "2019-04-01" @default.
- W2923929522 modified "2023-09-25" @default.
- W2923929522 title "Intermittent hypoxia increases VE-Cadherin cleavage in OSAS through ROS and HIF-1 pathways" @default.
- W2923929522 doi "https://doi.org/10.1016/j.acvdsp.2019.02.032" @default.
- W2923929522 hasPublicationYear "2019" @default.
- W2923929522 type Work @default.
- W2923929522 sameAs 2923929522 @default.
- W2923929522 citedByCount "0" @default.
- W2923929522 crossrefType "journal-article" @default.
- W2923929522 hasAuthorship W2923929522A5000401587 @default.
- W2923929522 hasAuthorship W2923929522A5027498618 @default.
- W2923929522 hasAuthorship W2923929522A5030907986 @default.
- W2923929522 hasAuthorship W2923929522A5040246127 @default.
- W2923929522 hasAuthorship W2923929522A5048658342 @default.
- W2923929522 hasAuthorship W2923929522A5061416491 @default.
- W2923929522 hasAuthorship W2923929522A5071764115 @default.
- W2923929522 hasConcept C123012128 @default.
- W2923929522 hasConcept C126322002 @default.
- W2923929522 hasConcept C134018914 @default.
- W2923929522 hasConcept C178790620 @default.
- W2923929522 hasConcept C185592680 @default.
- W2923929522 hasConcept C202751555 @default.
- W2923929522 hasConcept C2776006263 @default.
- W2923929522 hasConcept C2780796939 @default.
- W2923929522 hasConcept C2780972559 @default.
- W2923929522 hasConcept C28406088 @default.
- W2923929522 hasConcept C540031477 @default.
- W2923929522 hasConcept C55493867 @default.
- W2923929522 hasConcept C71924100 @default.
- W2923929522 hasConcept C7836513 @default.
- W2923929522 hasConceptScore W2923929522C123012128 @default.
- W2923929522 hasConceptScore W2923929522C126322002 @default.
- W2923929522 hasConceptScore W2923929522C134018914 @default.
- W2923929522 hasConceptScore W2923929522C178790620 @default.
- W2923929522 hasConceptScore W2923929522C185592680 @default.
- W2923929522 hasConceptScore W2923929522C202751555 @default.
- W2923929522 hasConceptScore W2923929522C2776006263 @default.
- W2923929522 hasConceptScore W2923929522C2780796939 @default.
- W2923929522 hasConceptScore W2923929522C2780972559 @default.
- W2923929522 hasConceptScore W2923929522C28406088 @default.
- W2923929522 hasConceptScore W2923929522C540031477 @default.
- W2923929522 hasConceptScore W2923929522C55493867 @default.
- W2923929522 hasConceptScore W2923929522C71924100 @default.
- W2923929522 hasConceptScore W2923929522C7836513 @default.
- W2923929522 hasIssue "2" @default.
- W2923929522 hasLocation W29239295221 @default.
- W2923929522 hasOpenAccess W2923929522 @default.
- W2923929522 hasPrimaryLocation W29239295221 @default.
- W2923929522 hasRelatedWork W1974766009 @default.
- W2923929522 hasRelatedWork W2042780225 @default.
- W2923929522 hasRelatedWork W2101520277 @default.
- W2923929522 hasRelatedWork W2128340364 @default.
- W2923929522 hasRelatedWork W2129989483 @default.
- W2923929522 hasRelatedWork W2551389730 @default.
- W2923929522 hasRelatedWork W2609226380 @default.
- W2923929522 hasRelatedWork W2738107143 @default.
- W2923929522 hasRelatedWork W4224052361 @default.
- W2923929522 hasRelatedWork W4289653811 @default.
- W2923929522 hasVolume "11" @default.
- W2923929522 isParatext "false" @default.
- W2923929522 isRetracted "false" @default.
- W2923929522 magId "2923929522" @default.
- W2923929522 workType "article" @default.